Estrogen in HRT
This is not medical advice — it is general information based on what you searched for that may help.
General information based on published sources and the symptoms you searched for. This isn't medical or legal advice, a diagnosis or a treatment plan. Please consult a doctor about your own symptoms. If your symptoms are severe or sudden, seek urgent care.
Evidence:Strong evidence
Estrogen is the hormone whose decline during perimenopause and menopause drives most of the classic symptoms — hot flashes, night sweats, and vaginal dryness among them. Replacing it is the core of hormone therapy (HRT), and it's graded Strong evidence by The Menopause Society as the most effective treatment for vasomotor symptoms and genitourinary syndrome of menopause, while also preventing bone loss.
Estrogen alone, or estrogen with a progestogen?
This is determined by one simple factor: whether you still have a uterus.
- Estrogen-only HRT is offered to people who've had a total hysterectomy. With no uterine lining left, there's nothing for unopposed estrogen to overstimulate.
- Combined HRT (estrogen plus a progestogen) is offered to people who still have a uterus, because estrogen alone can thicken the uterine lining over time, raising endometrial cancer risk — the progestogen protects against that. See our progesterone and progestogens page for more.
This isn't a preference call — it's a safety requirement based on your anatomy.
Forms and dose
Estrogen is available as pills, patches, gels, sprays, and (in low-dose vaginal form) creams, tablets, and rings for local symptoms only — see our dedicated vaginal estrogen page for that distinct use case. For systemic use, NICE recommends using the lowest effective dose, and the route you choose changes more than convenience — see HRT patch vs. pill for how it affects blood clot and stroke risk specifically.
Where this fits in the bigger picture
Estrogen's benefits and risks — breast cancer, blood clots, stroke — vary by type, route, and your personal history. See types of HRT for how the pieces fit together, who HRT may suit, and who needs specialist advice before narrowing down a specific approach, and our Does It Work? evidence directory if you want to compare it against non-hormonal options.
Use our treatment conversation builder to prepare for your appointment:
- Given whether I have a uterus, am I being offered estrogen alone or combined with a progestogen?
- What's the lowest dose and most suitable route for my specific symptoms and risk factors?
Where are you right now?
Still tracking
Not sure if your symptoms fit? Start tracking your daily patterns.
Log and spot your patterns with the symptom checklist →Ready to talk to a doctor
Have an upcoming appointment? Bring structured questions and your history.
Prepare your 10-minute doctor appointment questions →Already on treatment
Evaluating your response or wondering what to adjust next?
Explore evidence-graded treatment and lifestyle options →Questions people ask
Why do some women take estrogen alone, and others take it with a progestogen?
It depends on whether you have a uterus. Estrogen alone can thicken the uterine lining over time, raising the risk of endometrial cancer, so people who still have a uterus are offered estrogen combined with a progestogen to protect against that. People who've had a total hysterectomy can take estrogen alone, since there's no uterine lining to protect.
What form does estrogen come in?
Several forms exist, including pills, patches, gels, and sprays, and the choice of route affects more than convenience — it changes blood clot and stroke risk. See our patch vs. pill comparison for the specifics.
Related pages
References
- The 2022 Hormone Therapy Position Statement Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause (The North American Menopause Society, now The Menopause Society), 2022. Funding: Funded by donations to the NAMS Education & Research Fund; the statement reports no commercial support. Individual panel disclosures not yet reviewed..
- Menopause: identification and management (NG23), Recommendations. National Institute for Health and Care Excellence (UK), 2026.
Change log
- : Published explainer on estrogen in hormone therapy